Terrific @WaheedAhmed1! Thank you for including the link to your paper. At some point, I would like to discuss the feasibility of characterizing contrast induced nephropathy in the OHDSI network.
Great @mattspotnitz! Look forward to hearing from you , We have access to a prospective cohort of well-defined postoperative pts, ~5K. With regards to AKI and COVID perhaps further discussion via Slack/Teams might be fruitful to push things forward?
Did others in this group see the AllScripts study? It apparently found elevated risk for AKI, as well. (I haven’t seen the paper, only the coverage: https://www.washingtonpost.com/national/health-science/medical-databases-show-1-in-10-hospitalized-middle-aged-coronavirus-patients-in-us-do-not-survive/2020/04/11/284485a2-7bfe-11ea-b6ff-597f170df8f8_story.html)
After getting input from multiple sources, I think it is best to wait for the results of the COVID Characterization study from the study-a-thon and then reassess how to approach this topic. Thank you all for your interest!
Are there other characterization questions that have come up? I’m particularly interested in how coronavirus impacts HIV patients but have no data to contribute to that effort. Are there others who have expressed interest in that topic or other subgroups?
I was thinking that a leaderboard of urgent COVID questions could be useful. This would be a place to submit specific questions and where the community (or clinicians/researchers etc.) could vote on them to decide what was the most urgent question to address. Something similar to what is provided by pigeonhole.
A list of answerable COVID19 questions and a list of questions that are being answered would be very useful, thanks for the suggestion. But, apologies, I’m not in favour of voting to decide “the most important” because they will all be important to someone, somewhere and their loved ones.
Yes, I’d like to work on this- please count me in!
Medscape article relevant to this group
I believe this is the AllScripts study that found increased risk of AKI: https://jamanetwork.com/journals/jama/fullarticle/2765184?guestAccessKey=6ad3f237-3962-483e-9a30-81ef5ad2c40f&utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jama&utm_content=olf&utm_term=042220